Hedgehog (Hh) signaling is necessary for the induction and functional patterning of the pituitary placode, however the mechanisms by which Hh signals are interpreted by placodal cells are unknown. Here we show distinct temporal requirements for Hh signaling in endocrine cell differentiation and describe a dynamic Gli transcriptional response code that interprets these Hh signals within the developing adenohypophysis. Gli1 is required for the differentiation of selected endocrine cell types and acts as the major activator of Hhmediated pituitary induction, while Gli2a and Gli2b contribute more minor activator functions. Intriguingly, this Gli response code changes as development proceeds. Gli1 continues to be required for the activation of the Hh response anteriorly in the pars distalis. In contrast, Gli2b is required to repress Hh target gene expression posteriorly in the pars intermedia. Consistent with these changing roles, gli1, gli2a, and gli2b, but not gli3, are expressed in pituitary precursor cells at the anterior neural ridge. Later in development, gli1 expression is maintained throughout the adenohypophysis while gli2a and gli2b expression are restricted to the pars intermedia. Given the link between Hh signaling and pituitary adenomas in humans, our data suggest misregulation of Gli function may contribute to these common pituitary tumors.
Introduction
The vertebrate pituitary gland is comprised of a neurally derived lobe, the neurohypophysis, and an epidermally derived lobe, the adenohypophysis. The structure of the adenohypophysis is highly conserved across vertebrates, with the lobe being divided into two subdomains along the anterior/posterior (A/P) axis (Liem et al., 2001; Wilson and Wyatt, 1986) . The anterior region, or pars distalis (PD), contains lactotropes, corticotropes, thyrotropes, and gonadotropes, while the posterior region, the pars intermedia (PI), contains some thyrotropes and all melanotropes (Guner et al., 2008; Herzog et al., 2003; Sbrogna et al., 2003; Wilson and Wyatt, 1986) .
The adenohypophysis forms early in embryonic development as a midline cranial placode through a thickening and/or invagination of epithelial cells (Schlosser, 2006) . In mammals, oral ectoderm invaginates to form Rathke's pouch, which thickens to form the adenohypophysis. Fate mapping studies in mammals indicate that Rathke's pouch is derived from cells at the anterior neural ridge (ANR) of the neural plate stage embryo (Kouki et al., 2001) . Similarly, zebrafish fate mapping studies show that the adenohypophysis is derived from cells at the ANR that comprise an equivalence domain that can form pituitary or lens (Dutta et al., 2005) . The early developmental program for adenohypophysis formation appears to be largely conserved across vertebrate species, with a number of signaling molecules (e.g. sonic hedgehog, (Shh), fibroblast growth factor (Fgf), and bone morphogenetic protein (Bmp)) and transcription factors (e.g. Pitx3, Lim3) contributing to both the initial induction of the placode and the differentiation of specific endocrine cell types (reviewed in Pogoda and Hammerschmidt, 2007) .
The secreted protein Sonic hedgehog is necessary for pituitary formation across vertebrate species (Dutta et al., 2005; Herzog et al., 2003; Sbrogna et al., 2003; Treier et al., 2001) . Human (Roessler et al., 2003) , mouse (Treier et al., 2001) and zebrafish Hedgehog (Hh) pathway mutants lack a pituitary, with more severe loss of Hh signaling in zebrafish leading to the formation of an ectopic lens in place of the adenohypophysis (Karlstrom et al., 1999; Kondoh et al., 2000; Varga et al., 2001) . This requirement for Hh signaling in the developing pituitary placode appears to be direct based on the expression of Hh responsive genes in the adenohypophysis (Guner et al., 2008; Sbrogna et al., 2003) and on data showing that targeted disruption of Hh signaling in oral ectoderm causes pituitary hypoplasia and the loss of ventral cell types (Treier et al., 2001) . We previously showed that Hh signals from the central nervous system (CNS) are required to induce expression of the pituitary specific gene lim3 (lhx3) in pre-placodal cells at the ANR at around 15 h post fertilization (hpf) in zebrafish (Sbrogna et al., 2003) . Further, graded Hh and Fgf (likely Fgf3, Herzog et al., 2004 ) signals from the CNS play a role in functional patterning of the placode along the A/P axis and establishing the PD and PI regions early in placode development (Guner et al., 2008) . These studies indicate that Hh is one of the first inductive signals for pituitary cell fates, and that Hh continues to play a role in endocrine cell differentiation as the placode is patterned.
The Hh signaling pathway is highly conserved from insects to mammals, with Hh signals being mediated in responding cells by the Gli family of zinc finger transcription factors. Hh/Gli signaling can induce a variety of cellular responses depending on the context of signaling (Ruiz i Altaba et al., 2007) . These responses include cell differentiation through the activation and repression of homeobox transcription factors, as well as regulation of cell proliferation and cell survival (Cayuso et al., 2006) . In Drosophila, the cellular response to Hh is regulated by activator and repressor activities of a single bifunctional gli homologue, Cubitus interruptus (Ci). In the absence of Hh signals, Ci cleavage results in a truncated transcription factor that represses expression of Hh target genes. Signaling by Hh results in the formation of a full length protein that activates expression of Hh target genes (Aza-Blanc et al., 1997; Methot and Basler, 2001) . In vertebrates, these activator and repressor functions are distributed among at least three Gli proteins, with a complex code of activator and repressor Gli function determining the cellular response to different levels of Hh signals. In the mouse neural tube, Gli2 is a major activator of Hhmediated dorsoventral patterning events, while Gli1 appears to play a minor activator role, and both Gli2 and Gli3 have activator and repressor roles (Ruiz i Altaba, 1999) . In zebrafish, most aspects of Gli functionality are conserved, however Gli1 rather than Gli2 appears to be the major activator of the early Hh response in the CNS Tyurina et al., 2005; Vanderlaan et al., 2005) . Two gli2 genes (gli2a and gli2b) have been identified in zebrafish that are likely to have arisen as the result of a partial genome duplication in the teleost lineage (Ke et al., 2005) . While both Gli2 proteins appear to have similar Hh-dependent activator roles in the nervous system, the identification of an additional role for Gli2b in the regulation of cell proliferation suggests that there has been some divergence in the function of gli2a and gli2b over evolutionary time (Ke et al., 2008) .
Despite a well-established role for the Gli transcription factors in neural patterning, little is known about how the different gli genes function in endocrine tissues. A role for Gli-mediated Hh signaling in pituitary development has been demonstrated genetically, as zebrafish mutations in Gli1 lead to defects in pituitary patterning and cell specification Sbrogna et al., 2003) . These defects are less severe than those seen in mutations affecting Shh or Smoothened, the major transmembrane mediator of Hh signaling, suggesting multiple Gli genes may help mediate Hh signaling in the adenohypophysis. Here we show that Gli-mediated Hh signaling contributes to the functional patterning of the pituitary along the anterior/posterior axis of the adenohypophysis. Our studies uncover a specific temporal requirement for Hh/Gli signaling in the events of pituitary induction, in the proper patterning of the two subdomains of the adenohypophysis (the PD and PI), and in endocrine cell differentiation. Since altered Hh signaling has been associated with human adenomas (Vila et al., 2005) , these results also suggest that misregulated Gli1 and Gli2 function may be an important contributor to common endocrine tumors.
Materials and methods

Wild type and mutant zebrafish lines
Zebrafish lines were maintained at the University of Massachusetts, Amherst Zebrafish Facility. Embryos were incubated in embryo raising medium (ERM; 2 mM MgSO 4 , 2 mM KCl, 2 mM CaCL 2 , 0.5 mM NaH 2 PO 4 , 5 mM NaCl) at 28.5°C and staged as described (Kimmel et al., 1995) . Mutant lines used were you-too (yot ty17 ) and detour (dtr ts269 ) (Karlstrom et al., 1999 (Karlstrom et al., , 1996 .
In situ hybridization
Antisense digoxigenin or fluorescein labeled probes were generated against gli1 , gli2a (Karlstrom et al., 1999) , gli2b (Ke et al., 2005) , gli3 , nkx2.2a (Barth and Wilson, 1995) , ptc1 (Concordet et al., 1996 ), gh, tsh-β, prl, pomc (Herzog et al., 2003 , pitx3 (Dutta et al., 2005) , and pax7 (Seo et al., 1998) . Whole mount in situ hybridization was performed as previously described (Karlstrom et al., 1999) . Gene expression patterns were visualised using NBT/BCIP or Fast Red as the chromogenic substrate (Roche Ltd, Basel, Switzerland). Following completion of the staining reaction, embryos were cleared in 75% glycerol and examined using DIC optics.
Cyclopamine treatments
Embryos were treated with 100 μM cyclopamine (Toronto Chemical) (Incardona et al., 1998) by adding 10 μl of 10 mM stock solution (in 95% EtOH) to 1 ml of ERM starting at the time points indicated. Control embryos were treated simultaneously with an equal volume (10 μl) of 95% EtOH (cyclopamine carrier) in 1 ml ERM. Treatments were carried out in 12 well plates (n = 30 embryos/well) at 28.5°C. Embryos were dechorionated using 0.2 mg/ml pronase (Sigma) and fixed with 4% paraformaldehyde for in situ hybridization analysis.
Early mRNA and MO injections
For shh mRNA injections the shh/T7TS plasmid (Ekker et al., 1995) was linearized with BamH1 and transcribed using the Ambion Message Machine T7 capped RNA transcription kit (Ambion Inc., TX, USA). RNA was diluted in 1× Danio solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM Ca(NO 3 ) 2 , 5 mM Hepes, phenol red). Embryos were injected with approximately 100 pg RNA at the 1-2 cell stage using a pressure injector. Translation blocking morpholino oligonucleotides (MO) were purchased from Gene Tools LLC (Philomath, OR). Sequences were as follows: gli1MO: 5′CCGACACACCCGCTACACCCA-CAGT-3′, gli2aMO: 5′-GGATGATGTAAAGTTCGTCAGTTGC-3′, gli2bMO: 5′-AGCTGGAACACCGGCCTCCATTCTG-3′, and control MO: CCTCTTACCTCAGTTACAATTTATA. All MOs were injected alone or in combination at the 1-2 cell stage at a final concentration of 4 ng. Matched concentrations of standard control MOs were injected as a control for MO toxicity. Injected embryos were cultured in ERM at 28.5°C to 24-28 hpf or 48 hpf and fixed with 4% paraformaldehyde overnight at 4°C. At least three independent experiments were performed for each MO or combination of MOs. Replicates were subsequently analyzed using the Chi Square test of homogeneity to assess variation before the data were pooled. Statistical significance was verified using the Fisher Exact test. For endocrine cell counts, data were obtained from a minimum of 15 larvae for each experimental group. Statistical significance was established using one-way ANOVA, followed by Tukeys HSD test to identify significant groupings. Statistical computation was performed using software available on the VassarStats website (http://faculty.vassar.edu/lowry/VassarStats.html).
Late morpholino injections
To investigate later functions of gli2a and gli2b, MOs or a cocktail of at least 3 different antisense phosphorothioate-modified oligonucleotides (S-oligos) (Sigma-Genosys, The Woodlands, TX) were injected at the 17.5 hpf stage into the cavity just under the head and above the yolk. S-oligos contain sulfur in place of the non-bridging oxygen in the DNA phosphate backbone, which acts to stabilize the resulting DNA-RNA hybrid and target the bound RNA for degradation by RNase H. The sequences of the S-oligos were as follows; SGli2a-1: ggaTGATG-TAAAGTTCGTCAGttgC, SGli2a-2: ctcCTTCAGATGCACATgggT, SGli2a-3: ggcATGGTGCAAATGTGCTGatcT, SGli2a-4: ttaATATCTAGTTTGAACtacG. 80 μM total S-oligo or 4 ng of MO (gli1, gli2b, gli3) was injected in a volume of 0.5 nl injection solution containing 6% lipofectamine (Invitrogen, CA) and 0.1% phenol red.
Results
Distinct temporal requirements for Hh signaling in endocrine cell differentiation
Our previous work demonstrated that Hh signaling is required around 15 h post fertilization (hpf) for the induction of lim3 expression in the early placode, for placodal expression of the Hh responsive gene nkx2.2a, and for differentiation of Prolactin (Prl) secreting lactotropes (Sbrogna et al., 2003) . Different endocrine cell types are spatially organized along the A/P axis of the adenohypophysis by 48 hpf, and their anterior/posterior position roughly corresponds to their sensitivity to Hh signaling levels (Guner et al., 2008) . Further, endocrine cell types arise at different times, raising the possibility that Hh could regulate endocrine cell differentiation based both on time of differentiation and position in the placode. Anterior cell types expressing pomc (corticotropes) and prl (lactotropes) are the first to differentiate at approximately 23 hpf Liu et al., 2003) in the region that gives rise to the PD (Guner et al., 2008) . The pomc gene product is also expressed starting about 25 hpf by posterior melanotropes that reside in the PI (Guner et al., 2008; Liu et al., 2003) . tsh-β expressing thyrotropes and gh expressing somatotropes appear at approximately 40 and 42 hpf respectively, and are located more medially. gh cells are found exclusively in the caudal region of the PD, while tsh-β cells are located in both the caudal PD and in the PI (Fig. 1 , Guner et al., 2008) .
To determine the temporal requirement for Hh signaling in the induction of these endocrine cell types, we pharmacologically blocked Hh signaling at different times using the alkaloid Hh inhibitor cyclopamine (CyA) (Incardona et al., 1998) and counted endocrine cell numbers at 48 hpf.
As shown previously, blocking Hh signaling starting prior to somitogenesis (10 hpf) eliminated all hormone secreting cells (Figs. 1A, G, M), consistent with a role for Hh in inducing the entire placode (Sbrogna et al., 2003) . Blocking Hh signaling starting at midsomitogenesis stages (15 hpf) led to a major reduction in prl expressing lactotropes ( Fig. 1B ), while treatments after this time point did not significantly affect lactotrope numbers (Figs. 1C, D) . Consistent with a role for Hh in lactotrope cell differentiation, overexpression of Hh led to an increase in Prl cell numbers in 100% of embryos examined (n = 83), with ectopic cells residing at the anterior edge of the embryo, as well as in the eye (Fig. 1F ). The fact that ectopic endocrine cells are found in the area of the lens supports the idea that lens and pituitary precursors are part of an equivalence domain at the ANR (Dutta et al., 2005) , and further suggests that Hh signaling can cause lens precursors to transdifferentiate as endocrine cells.
Similar to lactotropes (prl), pomc expressing corticoptropes failed to differentiate in the PD when Hh signaling was blocked starting at 15 hpf ( Fig. 1B) . Unlike lactotropes, corticotrope differentiation was also blocked by treatments starting at 20 hpf (Fig. 1C) , showing a continued dependence on Hh signaling that lasts through 30 hpf. Posterior pomc expressing melanotropes were slightly reduced by all CyA treatments (Figs. 1A-D), indicating Hh signaling plays a more minor role in the differentiation of these cells in the PI. Hh injections expanded pomc expressing cells across the anterior forebrain and into the eye region (92%, n = 73), similar to prl cells ( Fig. 1F ).
Like anteriorly positioned corticotropes, Gh secreting somatotropes were very sensitive to the loss of Hh signaling throughout the first two days of development. Blocking Hh starting at either 10 or 15 hpf completely eliminated gh expressing cells (Figs. 1G, H) . Blocking Hh starting at 20 hpf eliminated most gh cells (Fig. 3I ), while blocking Hh at later timepoints (30-48 h) resulted in approximately half the number of cells (Fig. 3J ). Thus differentiation of somatotropes requires Hh signals over a much broader time window, at least from 10 to 30 hpf. Hh overexpression had a minor effect on gh expressing somatotropes, with 21% of shh mRNA injected embryos having ectopic cells (n = 42; Fig. 1L ). In contrast to lactotropes (prl) and somatotropes (gh), tsh-β secreting thyrotropes were only mildly reduced by the loss of Hh signaling from 10 to 30 hpf (Figs. 1N-P). Further, overexpression of Shh did not alter the overall number of thyrotropes, although ectopic tsh-β expressing cells were often found in the eye region (62%, n = 37; Fig. 1R ). Together, our data show that thyrotrope and melanotrope differentiation is largely independent of Hh signaling, while differentiation of somatropes, lactropes, and corticotropes requires Hh signaling. The time that Hh signaling is required varies for each endocrine cell type and may correspond to the time when hormone-specific precursor cells first differentiate.
Expression of gli genes in the developing adenohypophysis
Given the temporally distinct roles for Hh signaling in adenohypophysis development, and the demonstrated role for gli genes in pituitary development shown in the zebrafish dtr(gli1) and yot(gli2) mutants (Guner et al., 2008; Karlstrom et al., 1999; Sbrogna et al., 2003) , we next wondered which gli gene or genes were expressed in the developing placode. We carefully examined the onset of gli1, gli2a, gli2b and gli3 expression during induction of the adenohypophysis at the anterior neural ridge (ANR) as well as later when the PD and PI form along the anterior/posterior axis of the placode. Expression of the Hh responsive genes ptc1 and nkx2.2a in pre-placodal cells at the ANR at 14.5 hpf (11 somites) indicates that these cells directly respond to Hh signals prior to the onset of the pituitary specific gene lim3 (Dutta et al., 2005; Sbrogna et al., 2003) . We found that gli1 ( Figs. 2A, B) , gli2a (Figs. 2E, F), and gli2b (Figs. 2I, J), but not gli3 ( Fig. 2F inset, data not shown) were expressed in the pre-placodal cells at the ANR at the time that they express the Shh receptor ptc1, and just prior to the expression of the pituitary specific gene lim3 ( Fig. 2B inset, Sbrogna et al., 2003 ), suggesting these three gli genes might be responsible for interpreting the initial Hh signals that induce pituitary gene expression in pre-placodal cells at the ANR.
gli1, gli2a and gli2b continued to be expressed in cells spanning the anterior midline of the neural plate until approximately 21 hpf, when gli1 expression was downregulated in medial cells and more strongly expressed in lateral cells ( Fig. 2C ). At 21 hpf, gli2a and gli2b were expressed both medially and laterally at the ANR (Figs. 2G, K). By 30 hpf, expression of gli1, gli2a and gli2b were distinct and complementary, with gli1 expressed anteriorly in the PD (Fig. 2D ) and gli2a and gli2b expressed posteriorly in the PI (Figs. 2H, L) . This suggests that Gli1 and Gli2a and Gli2b may have different functions as the placode becomes patterned along the anterior-posterior axis and as these two distinct subdomains form (Guner et al., 2008) .
Overlapping functions for Gli1, Gli2a and Gli2b during adenohypophysis induction
To begin to uncover the Gli transcriptional response "code" that interprets Hh signals during adenohypophysis induction we next blocked Gli function either genetically or by injection of antisense morpholino oligonucleotides. While the adenohypophysis is completely absent in zebrafish mutants lacking Smoothened function (smo mutants) and is extremely reduced in yot(gli2aDR) mutant embryos (Sbrogna et al., 2003) , it is only slightly reduced in size in dtr(gli1) mutants. In addition, low-level expression of the Hh responsive gene nkx2.2a remains in the anterior region, the PD (Fig. 3B , Guner et al., 2008; Sbrogna et al., 2003) in the absence of Gli1 function. This strongly suggests that other Gli proteins positively mediate Hh signaling during placode induction. To determine which Gli proteins perform this activator function, we injected translation-blocking gli2a and/or gli2b morpholinos into dtr(gli1) mutant embryos. Knock-down of either Gli2a or Gli2b function was sufficient to abolish residual nkx2.2a expression in a significant proportion of dtr(gli1) mutants (Figs. 3D, F, Table 1 ). An additional increase in the penetrance of this phenotype was observed when both gli2a and gli2b MOs were co-injected into dtr mutants (Fig. 3H, Table 1 ). This indicates that either Gli2a or Gli2b can activate the low level of nkx2.2a expression seen in the absence of Gli1 function. Reducing Gli2a and/or Gli2b function in wild type embryos did not perceptably reduce nkx2.2a expression ( Figs. 3C, E, G) . Interestingly, loss of Gli2a and/or Gli2b function caused an expansion of nkx2.2a into the posterior region of the placode (the PI), as well as a posterior expansion of lim3 expression ( Figs. 3E, G) . This points to an additional repressor role for both the Gli2a and Gli2b proteins. gli3 MO injections did not affect pituitary development (data not shown). Together these data suggest that a threshold level of Gli activator function is needed for normal nkx2.2a expression. While Gli1 appears to mediate a majority of this activator function, Gli2a and Gli2b can also contribute as activators of the Hh response.
Further evidence that Gli1 is the major Shh activator during placode induction, with Gli2a and Gli2b playing minor activator roles, came from experiments in which the dominant repressor form of Gli2a expressed by the yot(gli2aDR) mutant was reduced using gli2a morpholino injections. Injecting gli2a MOs into yot(gli2aDR) mutant embryos partially rescued nkx2.2a expression in the pituitary (Fig. 3J) , with nkx2.2a expression being similar to that seen in dtr(gli1) mutants (Fig. 3B ). Since only truncated Gli2a proteins are made in yot(gli2aDR) mutants, these gli2a MO injected yot(gli2aDR) mutant embryos lack any possible Gli2a activator function and thus any activator function must be mediated by Gli1 and/or Gli2b. Further, since yot mutants express the Gli2aDR protein in the same cells in which normal Gli2a is expressed in wild type embryos (R.O.K unpublished data), this rescue suggests that the Gli2a repressor normally functions in the same cells as activator Gli proteins, implying a balance of Gli activator and repressor functions is established within individual responding cells. Interestingly, in clutches obtained from crosses between two yot( +/− ) adults, gli2b MO injection led to a reduction in nkx2.2a expression in 58% of embryos. Subsequent genotyping confirmed these embryos to be yot +/− heterozygotes (n = 15, data not shown). This suggests that Gli2b contributes a weak activator function that is uncovered when Gli activator function is attenuated by the presence of one copy of the gli2a dominant repressor gene. Together, these data show that overall levels of Gli1, Gli2a and Gli2b activator function are important for the proper Hh transcriptional response in the pituitary.
Gli function and endocrine cell differentiation
Having demonstrated overlapping activator functions for Gli1, Gli2a and Gli2b during Hh-mediated induction of the adenohypophysis, we next sought to determine how each of the Gli genes contributes to endocrine cell differentiation and thus the functional patterning of the pituitary. To dissect overlapping and unique roles for each of the Gli genes, we analyzed the expression of prl, pomc, gh and tsh-β in embryos injected with different gli morpholinos.
Loss of Gli1 function, either in dtr(gli1) mutants or gli1 MO injected embryos, led to the loss or reduction of anterior pomc (pomc-a), prl and gh expressing cells (Figs. 4E, F , H, U, Table 2 , Sbrogna et al., 2003) , demonstrating the requirement for Gli1 in the differentiation of somatotropes as well as the most anterior endocrine cell populations (lactotropes and corticotropes) of the PD. In contrast, loss of Gli1 had little effect on thyrotropes (tsh-β) or posterior pomc (pomc-p) expressing melanotropes (msh) (Figs. 4G, H, U) , consistent with a minimal role for Gli-mediated Hh signaling in PI differentiation (Guner et al., 2008) .
Loss of either Gli2a or Gli2b function moderately reduced the number of anterior pomc expressing cells (corticotropes), an effect that was enhanced when both Gli2a and Gli2b were reduced (Figs. 4L, P, U). This suggests a minor activator role for both of these Gli proteins in this cell population. No significant difference was observed in the number of prl, gh, tsh-β, and pomc-p populations following knockdown of Gli2a function (Fig. 4U, Table 2 ), however prl cells were mispositioned posteriorly in 40% of embryos examined (n = 20, Fig. 4I ) suggesting that Gli2a may act to restrict anterior fates from the posterior region. In contrast, loss of Gli2b function led to a significant increase in prl and tsh-β expressing cells, suggesting that Gli2b normally functions to repress differentiation of these cell types (Figs. 4I, K, U, Table 2 ). Coinjection of gli2a and gli2b MOs did not increase prl cell numbers beyond that observed following knock-down of Gli2b alone (Figs. 4M, U, Table 2 ), indicating Gli2b but not Gli2a negatively regulates prl cell numbers. These results point to distinct functions for the different gli genes in different endocrine populations.
Given this complex code of Gli function, we next wondered whether Gli1 activator function was working to overcome Gli2 repressor function, similar to the situation in the limb, where loss of Hh function can be rescued by the simultaneous loss of Gli3 repressor (te Welscher et al., 2002) . To determine how Gli1 interacts with Gli2a and Gli2b in the placode, we coinjected gli1 MOs with gli2a and/or gli2b MOs. Simultaneous knock-down of all three Gli genes (gli1, gli2a and gli2b) led to a significant reduction in all endocrine cell types, with the exception of tsh-β cells (Figs. 4Q-U) . This reduction is similar to, but less severe than that seen in yot(gli2DR) mutants, which lack most endocrine cell types (data not shown, Sbrogna et al., 2003) .
Notably, loss of Gli2a and/or Gli2b function did not rescue the loss of cells seen in gli1 MO injected embryos, indicating Gli1 function does not merely act to counter Gli2 repressor roles. Loss of Gli1 function did eliminate the expansion of prl and tsh-β populations seen following gli2b MO injection (Figs. 4Q, S, U) , indicating that increases in these cell numbers require Gli1 activity. While tsh-β cells are the least responsive to Gli manipulations, a balance of Gli repressor and activator function does appear to be important for regulating correct tsh-β cell numbers. Co-injection of gli1, gli2a, and gli2b MOs eliminated the increase in cell numbers seen when gli2b MOs were injected alone (Figs. 4S, U) , restoring tsh-β cell numbers to wild type levels (Table 2) .
In summary, our loss of function studies reveal a complex code of Gli function in the differentiation of endocrine cells that helps regulate endocrine cell numbers. Gli1 appears to be the major activator of Hhmediated endocrine cell differentiation, with Gli2a and Gli2b also playing minor activator roles for some cell types. Gli1 is required for differentiation of somatotropes (gh) and corticotropes (pomc-a) in the PD, but does not appear to play a role in differentiation of medially located thyrotropes (tsh-β) or posteriorly located melanotropes (pomc-p). This is consistent with the requirement for high levels of Hh activation in PD formation but not PI formation (Guner et al., 2008) . Gli2b seems to act as a repressor of prl and tsh-β cell differentiation, and may do so by repressing Gli1 activator function.
Distinct late functions for Gli1 and Gli2 in pituitary patterning
We next wondered how the different activator and repressor functions of Gli1 and Gli2 might be regulated. In the zebrafish CNS, distinct functions for Gli3 appear to be temporally regulated, with Gli3 activating the Hh response early in development, and then repressing Hh target genes at later times . Based on the changing expression pattern of gli2a and gli2b in the placode (Fig. 2) , we hypothesized that these proteins might function as activators of a Hh transcriptional response during the early induction phase of placode development, and then switch to repressors of the Hh response as the placode becomes functionally patterned. To test this hypothesis we injected antisense oligonucleotides (thioester containing S-oligos) or MOs near the pituitary placode at 17.5 hpf (Fig. 5A) , after Hh-mediated induction of pituitary specific genes at the ANR had occurred at approximately 15 hpf (Sbrogna et al., 2003) . We then assayed injected embryos at 40 hpf to determine the effects on the differentiation of anterior lactotropes (prl) and corticotropes (pomc-a) as well as posterior melanotropes (pomc-p).
To first prove that late antisense oligonucleotide injections could effectively block late gli function, we injected a well characterized gli3 MO into the spinal cord at late somitogenesis stages (Tyurina et al., Table 2 Endocrine cell counts following single and combinatorial Gli MO knock-down 2005). Injection of gli3 MOs at 17.5 hpf led to an expansion of the Hh target gene ptc1 into the dorsal spinal cord (Fig. 5C ), consistent with loss of Gli3 repressor function at this time .
Injection of gli1 MOs ventral to the forebrain at 17.5 hpf reduced both nkx2.2a and prl expression in the pituitary placode, with both domains being restricted to the mid region of the placode (Fig. 5E) . These results show that Gli1 continues to activate the Hh response during later pituitary development, and further confirm that late MO injection can affect gene function. We next injected gli2 MOs or Soligos at 17.5 hpf. In contrast to Gli1, late loss of Gli2a function led to an expansion of nkx2.2a expression into the posterior region of the adenohypophysis (Fig. 5F ). Loss of late Gli2a function also led to an expansion of lactotropes (prl) into the posterior region of the placode (Fig. 5I) as was seen following early gli2a MO injections (Fig. 4I) . Similar to gli2a, injection of gli2b MOs caused an expansion of both nkx2.2a and prl expression into the posterior placode (Figs. 5G, J) . This expansion of the anterior marker nkx2.2a and of anterior cell types indicates that Gli2a and Gli2b function to repress Hh-mediated differentiation of anterior cell types in the posterior region of the pituitary.
Discussion
Gli transcriptional response code is required for adenohypophysis induction and formation of the PD and PI The adult adenohypophysis is composed of two subdomains, the anterior pars distalis (PD) and the posterior pars intermedia (PI), a structural division that is conserved across vertebrate species. In zebrafish, the PD forms closer to the anterior source of Shh in the CNS while the PI forms close to a posterior source of Fgf3 (Fig. 6B , Guner et al., 2008; Liu et al., 2008) . Recent evidence from our lab suggests that graded Shh and Fgf signaling from the CNS helps establish these two subdomains from the earliest stages of placode development (Guner et al., 2008) . Here we focus on how graded Hh signals are interpreted by cells in the pituitary placode. In the CNS, graded Hh signals are converted into graded levels of Gli transcriptional activator and repressor function (Jacob and Briscoe, 2003; Stamataki et al., 2005) that then influence the transcriptional program in cells to establish different domains of gene expression along the dorsal/ventral axis. We show that a complex code of Gli activator and repressor function is similarly required for patterning of the adenohypophysis. Gli1, Gli2a and Gli2b mediate a Hh transcriptional response that is required for normal induction of the placode and for establishing proper gene expression domains that define the PD and PI.
Initially gli1, gli2a and gli2b are expressed in pitx3-positive cells that span the ANR in a region that can form either lens or adenohypophysis (Fig. 6A , Dutta et al., 2005) . Midline pre-placodal cells that contribute to the adenohypophysis begin to express nkx2.2a and ptc1 just prior to the initiation of the pituitary specific gene lim3 (lhx3), indicating they are responding to Hh signals. At this early stage of placode induction, Gli1, Gli2a, and Gli2b all have overlapping roles as activators of this Hh response, with Gli1 acting as the primary activator and Gli2a and Gli2b providing more minor activator roles (Fig. 6A ). Unlike the situation in the CNS, gli3 does not appear to be expressed in this Hh responsive field, and loss of Gli3 function had no effect on pituitary development.
As placodal cells coalesce toward the midline and move ventrally, the central/anterior region remains closer to the source of Hh and continues to express nkx2.2a, indicating a continued maximal Hh response (Fig.  6B ). Posterior regions become more distant from the source of Shh, lose nkx2.2a expression and begin to express pax7, a gene repressed by Hh signals (Fig. 6B , Briscoe et al., 2000; Guner et al., 2008) . This suggests that as posterior placodal cells move away from the CNS source of Shh, signaling levels fall below a critical threshold and a distinct transcriptional response is initiated posteriorly. The time of exposure to Shh may also contribute to this differential transcriptional response, as anterior cells experience Shh signals over a longer time period than posterior cells (Dessaud et al., 2007) . In either case, this differential Hh transcriptional response may mark the first division of the adenohypophysis into two domains that form the PD and PI.
During these placodal cell movements, Gli1 (also a transcriptional target of Hh signaling) is maintained in the anterior region (PD) and continues to positively mediate the response to Hh in the PD. In contrast, Gli2a and Gli2b become restricted to the PI. At these times, Gli2a and Gli2b function may be necessary to establish and maintain a balance of Gli activator and repressor functions, as indicated by the expansion of nkx2.2a expression into the PI following loss of Gli2b. Partial rescue of nkx2.2a expression following gli2a MO injection into yot(gli2aDR) mutant embryos suggests that a balance of Gli1 activator and Gli2 repressor function may initially act within the same cells to initiate the formation of distinct cell types (dashed lines in Fig. 6B ). Our late MO injections indicate that this spatially distinct Gli code (Gli1 activator anteriorly, Gli2a and Gli2b repressor posteriorly) is then important for maintaining proper gene expression in the PD and PI. This later role of Gli2a and Gli2b in repressing Hh signaling in the PI is analagous to the role played by Gli3 in the dorsal spinal cord (Jacob and Briscoe, 2003; Tyurina et al., 2005) , limiting the distance over which Hh can act and helping to establish distinct precursor populations in different anterior/posterior positions in the placode. In this case, this spatially distinct transcriptional response may also help establish a border that results in formation of the PD and PI.
Gli/Hh signaling regulates endocrine cell number and position
Different endocrine cell types appear over a wide range of developmental stages and at distinct positions within the placode. The fact that the timing, position, and number of each endocrine cell type are highly reproducible between individual zebrafish embryos suggests a tight regulation of cell differentiation that may impact on endocrine function. Given the established role for Hh as a morphogen in the spinal cord (reviewed in Ingham and McMahon, 2001) and the position of Hh dependent endocrine cells relative to the source of Hh, it is possible that Hh is similarly acting as a morphogen to guide differentiation of endocrine precursor cells in the adenohypophysis (Guner et al., 2008) . Using cyclopamine to inhibit Hh signaling at different times in placode development, we uncovered distinct temporal requirements for Hh in endocrine cell differentiation, suggesting that changing positions of endocrine precursors relative to the source of Hh may also influence this process. Gain of Hh function greatly expanded anterior cell types, suggesting that Hh levels regulate differentiation and/or proliferation of some but not all endocrine cell types. Consistent with this differential role for Hh in endocrine cell differentiation, different gli genes are required to establish the correct pattern and number of endocrine cell types within each subdomain of the pituitary. Gli1 is required for normal numbers of somatotropes (gh), lactotropes (prl) and anterior corticotropes (pomc-a) in the PD. Gli2a and Gli2b together are required for normal numbers of pomc-a and gh cells in the PD, and for pomc expressing cells in the PI. Gli2b also plays a role in restricting prl and tsh-β cell numbers, with loss of Gli2b function leading to a dramatic increase in these cell types. This expansion in cell numbers is dependent on Gli1 function, consistent with a role for Gli2b as a repressor of Hh-mediated cell differentiation at later time points. Knockdown of Gli2a and Gli2b affected endocrine cell position in both the pituitary and hypothalamus, consistent with pattering roles in both tissues.
Intriguingly, two cell types that reside in the middle region of the pituitary, somatotropes (gh) and thyrotropes (tsh-β), have very different requirements for Hh signals. Somatotropes, like lactotropes, require Hh/ Gli signals to differentiate, while thyrotropes do not. On the surface, this would argue against a gradient model for Hh and suggest that the position of a differentiating cell relative to the source of Hh does not affect precursor identity. However, it was recently reported that teleost somatotropes and lactotropes may arise from a common precursor cell called the mammosomatotrope that secretes both Gh and Prl (Villaplana et al., 2000) . If a common precursor for somatotropes and lactotropes were located near the source of Hh, with later cell migration leading to final endocrine cell position in the adenohypophysis, this could explain the similar sensitivity of these two cell types to Hh signals and fit with a morphogen model. It will be necessary to identify progenitor specific markers to distinguish between these possibilities.
Downstream of the Gli code
How might the Gli transcription factors regulate the relative numbers of endocrine cell types in the pituitary? Clearly the combination of Gli activator and repressor functions must result in unique transcriptional programs that differ across the placode. One candidate for a downstream target of this differential Gli code is Notch signaling. Though not required for initial placode formation, Notch appears to act on early placodal cells to promote the differentiation of somatotropes (gh), corticotropes (pomca) and melanotropes (pomc-p), and restrict differentiation of lactotropes (prl), thyrotropes (tsh-β) and gonadotropes (Dutta et al., 2008) . Based on these findings, it was proposed that long range signals, such as Hh and FGF, act early to induce and help pattern the early pituitary placode, establishing a series of regionally distinct subdomains along the A/P axis. Notch signaling appears to act within these subdomains to regulate choices between cell fates, and thus regulate the numbers of hormone cell types, presumably by lateral inhibition.
Interestingly, loss of Notch function was found to result in an increased number of lactotropes (prl) and thyrotropes (tsh-β), similar to the situation observed following knock down of Gli2b function. Dutta et al., (2008) suggest that lactotropes and thyrotropes constitute the primary cell fates within the placode and that loss of Notch function therefore leads to an increase in lactotropes and a concomitant decrease in corticotropes (the secondary cell fate) in the PD. While these results are consistent with a model in which Hh/ Gli signaling acts upstream of Notch in the specification of hormone cell types, they do not shed light on the loss of anterior cell types (both lactotropes and corticotropes) observed following knock-down of Gli1 function. An alternative explanation may be that the specific Gli code Fig. 6 . The Gli response code to Hh signaling during adenohypophysis development. (A) Schematic dorsal view of the head region at 15 hpf when pituitary specific genes are first induced at the anterior neural ridge (ANR). gli1, gli2a, and gli2b are expressed in the entire pitx3 positive domain (red and green regions). Shh signals (black) from the CNS induce nkx2.2a and lim3 expression in the central domain (red), which gives rise to the adenohypophysis (ah). At this stage Gli1, Gli2a and Gli2b function together to activate the Hh response in these cells. Medial cells coalesce toward the midline and migrate ventrally as the placode forms (arrows). (B) Lateral schematic views of the adenohypophysis at 30 and 42 hpf. Ventral movements bring the placode ventral/posterior to the source of Shh (black) in the hypothalamus. Fgf3 (purple) is expressed posterior to the placode. gli1 expression becomes restricted anteriorly to the PD (red) while gli2a and gli2b expression become restricted to the PI (orange). This change in expression coincides with a change in Gli function. Gli1 continues to function as an activator of Hh responsive genes, while Gli2a and Gli2b switch to repressors of the Hh response. Gli genes also play distinct roles in endocrine cell differentiation throughout these stages. directs the expression of precursor-specific transcription factors that in turn define different precursor populations upon which Notch will act. Establishing the transcriptional output of each of the Gli transcription factors will therefore be necessary to identify key determinants for these progenitor populations and understand the coordinated action of both long-range and short-range signals in specification of endocrine cell fate in the pituitary.
Hh/Gli signaling and pituitary adenomas
Misregulation of Hh/Gli signaling has been implicated in several developmental disorders that affect the pituitary, including Holoprosencephaly and Pallister-Hall syndrome (Bose et al., 2002; Kalff-Suske et al., 1999; Ming et al., 1998; Ruiz i Altaba, 1999) . As with most developmentally important signaling systems, misregulation of Hh signals post embryonically is associated with cancer, including medulloblastoma and basal cell carcinoma (Ruiz i Altaba et al., 2004; Scott, 2003) . Hh misregulation has also been linked to common pituitary adenomas, with cell culture data suggesting that Hh signalling may negatively regulate endocrine cell proliferation in these tumors (Vila et al., 2005) . Pituitary adenomas affect up to 17% of the population (Ezzat et al., 2004) , making these among the most common human tumors. Despite this prevalence in the population, the molecular mechanisms underlying the occurrence of pituitary adenomas are poorly understood. Here we provide data suggesting specific roles for Gli genes in zebrafish endocrine cell differentiation, work that should inform studies into the mechanisms that cause the misregulation of endocrine cell proliferation during pituitary tumorogenesis in humans. Understanding how Gli proteins mediate Hh signaling during normal development may thus shed light on ways to treat and hopefully prevent some of these tumors.
